Skip to main content
. 2023 Nov 27;130(5):703–715. doi: 10.1038/s41416-023-02502-9

graphic file with name 41416_2023_2502_Figa_HTML.jpg

The positive aspects of drug repurposing in oncology are underscored here; encompassing personalized treatment, accelerated development, market opportunities for shelved drugs, cancer prevention, expanded patient reach, improved patient access, multi-partner collaborations, increased likelihood of approval, reduced costs, and enhanced combination therapy.